InvestorsHub Logo

TraderAI

07/31/22 1:13 PM

#111632 RE: hssbwwmp #111631

Two things lead me to believe this may never happen or be approved:

1) They claimed IND filing with FDA to get a free no charge filing AND free patent as long as it’s filing with a priority US patent filing and it was all covid related.

There was an issue and more info was requested, and to my knowledge, it was never followed up on. That’s why I don’t think there is much or any acknowledgment of a FDA or patent from 2020.

2) The message from the FDA and Slilaty as of late is quite similar to what I believe happened in 2020:

File No. 333-264830

Dear Dr. Slilaty:

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Alyssa
Wall at 202-551-8106 with any questions.

Sincerely,
Division of Corporation Finance

Office of Trade & Services
cc: Jeff Cahlon”